Enhanced lung disease and Th2 response following human metapneumovirus infection in mice immunized with the inactivated virus

scientific article published on December 2007

Enhanced lung disease and Th2 response following human metapneumovirus infection in mice immunized with the inactivated virus is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1099/VIR.0.83250-0
P698PubMed publication ID18024909
P5875ResearchGate publication ID5822147

P50authorGuy BoivinQ90829727
Marie-Ève HamelinQ92970053
P2093author name stringChristian Couture
Melanie K Sackett
P433issuePt 12
P407language of work or nameEnglishQ1860
P921main subjectHuman metapneumovirusQ743338
immunizationQ1415366
lung diseaseQ3392853
P304page(s)3391-3400
P577publication date2007-12-01
P1433published inJournal of General VirologyQ6295245
P1476titleEnhanced lung disease and Th2 response following human metapneumovirus infection in mice immunized with the inactivated virus
P478volume88

Reverse relations

cites work (P2860)
Q37124759A live attenuated human metapneumovirus vaccine strain provides complete protection against homologous viral infection and cross-protection against heterologous viral infection in BALB/c mice
Q37713874Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.
Q47160156Detection of Nuclear Protein Profile Changes by Human Metapneumovirus M2-2 Protein Using Quantitative Differential Proteomics
Q89860924Engineering of Live Chimeric Vaccines against Human Metapneumovirus
Q89481911Evaluation of pre- and post-fusion Human metapneumovirus F proteins as subunit vaccine candidates in mice
Q55012068Human metapneumovirus - what we know now.
Q27694039Human metapneumovirus in adults
Q27692700Human metapneumovirus: review of an important respiratory pathogen.
Q26782209Immune Response to Human Metapneumovirus Infection: What We Have Learned from the Mouse Model
Q45216908Immunogenicity and efficacy of two candidate human metapneumovirus vaccines in cynomolgus macaques
Q40590076Metapneumovirus Infections and Respiratory Complications.
Q34981539Modulation of protease activated receptor 1 influences human metapneumovirus disease severity in a mouse model
Q38524373New Approaches for Immunization and Therapy against Human Metapneumovirus
Q28474889Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets
Q90417639Prophylactic and therapeutic approaches for human metapneumovirus
Q27330166Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease risk
Q38008607Recent developments with live-attenuated recombinant paramyxovirus vaccines
Q27023742Recent vaccine development for human metapneumovirus
Q92827733Role for maternal asthma in severe human metapneumovirus lung disease susceptibility in children
Q60923277Small Animal Models of Respiratory Viral Infection Related to Asthma
Q39166925Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in mice